FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study-Reference-Cited by-同舟云学术

FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study

Published:2020-06-12 Issue:5 Volume:98 Page:421-428
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Sorigue Marc¹^ORCID,Junca Jordi¹,Ferra Christelle²,Marce Silvia¹,Ruiz‐Xivillé Neus¹,Pinyol Laia¹,Cabezon Marta¹,Espasa Andrea¹,Dominguez Diana¹,Lopez‐Viaplana Laia³,Ruiz Rocio⁴,Buch Joan⁵,Plensa Esther³,Mostacedo Silvia‐Zdenka⁵,Aranda Jessica⁴,Vergara Sara¹,Raya Minerva¹,Granada Isabel¹,Tapia Gustavo⁶,Navarro Jose‐Tomas¹,Beà Silvia⁷⁸⁹,Zamora Lurdes¹

Affiliation:

1. Hematology Laboratory ICO‐Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona Badalona Spain

2. Department of Clinical Haematology ICO‐Hospital Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autònoma de Barcelona Badalona Spain

3. Department of Hematology Hospital de Mataro Spain

4. Institut Josep Carreres contra la leucemia Badalona Spain

5. Department of Hematology Hospital de Calella, Calella and ICO‐Girona Girona Spain

6. Department of Pathology Hospital Germans Trias i Pujol Badalona Spain

7. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

8. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain

9. University of Barcelona Barcelona Spain

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21890

Reference24 articles.

1. Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways

2. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals

3. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

4. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B‐cell disorders;Hjalmar V.;Haematologica,1998

5. Chronic Lymphocytic Leukemia With t(14;19)(q32;q13) Is Characterized by Atypical Morphologic and Immunophenotypic Features and Distinctive Genetic Features

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?;Hematology, Transfusion and Cell Therapy;2024-08

2. CD5‐negative chronic lymphocytic leukemia: Does this entity really exist?;Cytometry Part B: Clinical Cytometry;2023-11-28

3. Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker;Journal of Cancer Research and Clinical Oncology;2023-07-20

4. Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders;Critical Reviews in Clinical Laboratory Sciences;2022-09-06

5. Issue Highlights—July 2022;Cytometry Part B: Clinical Cytometry;2022-07